Nicotine pouches

Spitless pouch dollar sales jumped 25.9% to $7.41 billion in the 52 weeks ending July 12, 2026, and now account for 54.8% of the entire U.S. smokeless category — meaning pouches have officially flipped the old chew-and-snuff market and become the majority product, pulling every new convenience-store shopper with them.

In June 2026, the FDA allowed Zyn to be marketed with the specific claim that it puts users at lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis versus cigarettes — the first modified-risk order ever granted to a nicotine pouch, giving mainstream buyers a government-stamped permission slip to switch.

Global pouch sales hit 34 billion units in 2025, up 660% from 2020, and the market is projected to reach $25 billion annually by 2028 — a growth pace faster than the entire global energy drink market, which means category awareness and retail shelf space are still expanding, not contracting.